APRIL 9, 2015
Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials
Welcome and Overview
Victor Dzau, M.D.
President, National Academy of Medicine
Antonia M. Villarruel, Ph.D.
Dean, College of Nursing, University of Pennsylvania
Jonca Bull, M.D.
Director, Office of Minority Health, U.S. Food and Drug Administration (FDA)
Panel 1: Historical Perspectives and Context
Moderator: Chazeman Jackson, Ph.D., Office of Minority Health, U.S. Department of Health and Human Services
Amelie Ramirez, Dr.P.H.
University of Texas Health Sciences Center
Otis Brawley, M.D., F.A.C.P.
American Cancer Society
Charles Rotimi, Ph.D.
National Institutes of Health (NIH)
|10:30 a.m.–12:00 p.m.||
Panel 2: Scientific Issues: Clinically Meaningful Inclusion
Moderator: Allan Goldberg, M.D., Merck & Co., Inc.
Panel 3: Recruitment and Retention Issues: Patient, Provider, Institutional, and System Barriers
Moderator: Deidra Crews, M.D., S.C.M., Gilbert S. Omenn Anniversary Fellow of the Institute of Medicine, Johns Hopkins University
Connie Ulrich, Ph.D., R.N., F.A.A.N.
University of Pennsylvania
Jonathan Ellen, M.D.
Johns Hopkins All Children’s Hospital
Moon Chen, Ph.D., M.P.H.
University of California, Davis
Panel 4: Best Practices and Policy Recommendations
Moderator: Francisco García, Pima County Health Department
Karen Kim, M.D.
University of Chicago
Teshia Solomon, Ph.D.
University of Arizona
Sandra E. Brooks, M.D., M.B.A.
University of Louisville
Toni Villarruel, Ph.D., R.N., F.A.A.N.
Barbara Buch, M.D.
This page intentionally left blank.